Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
Authors
Keywords
TP53, myelodysplastic syndromes, hypomethylating agents
Journal
Oncotarget
Volume 7, Issue 12, Pages -
Publisher
Impact Journals, LLC
Online
2016-02-13
DOI
10.18632/oncotarget.7290

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.